Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 03, 2026
TickeronGET DAILY SIGNALS
Intrepid Potash (IPI) Reports Q3 2026 Results with Trio Gains Offsetting Potash Pressure

Intrepid Potash (IPI) Reports Q3 2026 Results with Trio Gains Offsetting Potash Pressure

Key Takeaways

  • Intrepid Potash (NYSE: IPI) reported third-quarter 2026 revenue of roughly $51.0 million, essentially flat versus $50.8 million in the year-ago period.
  • Adjusted (non-GAAP) earnings per share (EPS) came in at $0.14, modestly ahead of consensus estimates.
  • Net income from continuing operations rose to about $1.7 million ($0.13 per diluted share), up sharply from $0.7 million a year earlier.
  • Adjusted EBITDA climbed to $11.7 million from $10.7 million, supported by a 19% jump in Trio® production.
  • Management raised full-year 2026 Trio® production guidance to 305,000–315,000 tons and lifted capital expenditure guidance to about $45 million.
  • The company ended the quarter with net cash and short-term investments of $161.4 million, giving it flexibility for buybacks and growth projects.

Earnings Context and Why It Matters

Intrepid Potash is the only U.S. producer of muriate of potash, a key potassium-based fertilizer, and it also sells a specialty fertilizer called Trio®. Because fertilizer demand and pricing are closely tied to agricultural cycles and crop economics, quarterly results offer a useful read on the broader farm-input market. I was watching this report for signs that higher realized prices and improved Trio® operations could offset softer potash volumes. The print delivered a mixed picture: profitability improved year over year, but a dip in potash shipments and a higher-cost sales mix trimmed that segment's margin, underscoring the importance of production efficiency as the company pursues a larger growth plan.

Reported Results

For the three months ended September 30, 2026, Intrepid Potash reported total revenue of approximately $51.0 million, essentially in line with the $50.8 million recorded a year earlier. Adjusted (non-GAAP) EPS of $0.14 came in modestly ahead of consensus, while net income from continuing operations increased to about $1.7 million, or $0.13 per diluted share, up from $0.7 million, or $0.05 per diluted share, in the prior-year quarter. Adjusted EBITDA rose to $11.7 million from $10.7 million. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Segment results were uneven. Potash revenue declined to roughly $31.3 million from $32.5 million, as sales volumes slipped about 5% to 59,000 tons on shipment timing, even as the average net realized price rose 3% to $394 per ton. Potash gross margin narrowed, pressured by a higher-cost production mix. By contrast, Trio® revenue increased 5% to about $19.1 million, with the average net realized price rising to $408 per ton and gross margin up roughly 33% on lower per-ton costs and a 19% production gain.

Management also raised full-year 2026 Trio® production guidance to 305,000–315,000 tons and lifted capital expenditure guidance to approximately $45 million, while providing fourth-quarter sales volume and pricing ranges for both product lines.

Market Reaction and Investor Sentiment

Heading into the release, sentiment around Intrepid Potash had been shaped by improving Trio® pricing and the company's efforts to raise production, but also by a seasonally soft third quarter and lingering concern over potash shipment timing. The mixed nature of the results — adjusted EPS slightly ahead of estimates and revenue roughly in line, offset by softer potash volumes and a higher-cost mix — left investors weighing improved profitability against segment-specific weakness. The raised Trio® guidance, increased capital spending plan, and the announcement that the company was selected for roughly $139 million in proposed USDA matching funding under the FIELDS program for a potential sulfate of potash facility near Carlsbad, New Mexico, provided additional catalysts for the market to digest.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors will focus on whether Intrepid Potash can sustain its Trio® momentum while stabilizing potash volumes and costs. Management's plan to invest roughly $16 million in 2027 to add about 30,000 tons of annual Trio® production, with full-year 2027 Trio® production targeted at approximately 320,000 to 330,000 tons, signals confidence in continued demand for its specialty fertilizer.

On the potash side, the company intends to invest around $20 million in mine development projects in 2027, aiming to lift annual production by roughly 20,000 to 30,000 tons versus the trailing three-year average. Executing these projects on time and on budget will be key, particularly given the higher-cost production mix that pressured potash margins this quarter. From what I see, realized pricing across both segments and agricultural demand heading into the spring application season remain important to track.

Using AI Tools in My Research Process

When analyzing names like IPI, I often turn to Tickeron’s AI-powered tools to quickly filter for technical patterns and fundamentals. The AI Screener stands out for its ability to surface comparable setups in the agricultural chemicals space, helping me cross-check earnings momentum against peers without spending hours on manual scans. It has become a regular part of how I evaluate sector trends during earnings season.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IPI

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


IPI's RSI Oscillator climbs out of oversold territory

The RSI Oscillator for IPI moved out of oversold territory on October 23, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 26 of the 31 cases the stock moved higher. This puts the odds of a move higher at 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 59 cases where IPI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.

The Moving Average Convergence Divergence (MACD) for IPI just turned positive on October 26, 2026. Looking at past instances where IPI's MACD turned positive, the stock continued to rise in 34 of 42 cases over the following month. The odds of a continued upward trend are 81%.

Following a +1.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where IPI advanced for three days, in 205 of 267 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

IPI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IPI as a result. In 75 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.

The 10-day moving average for IPI crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.

The 50-day moving average for IPI moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IPI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

The Aroon Indicator for IPI entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.809) is normal, around the industry mean (-0.403). P/E Ratio (15.573) is within average values for comparable stocks, (8.767). Projected Growth (PEG Ratio) (0.220) is also within normal values, averaging (0.867). IPI's Dividend Yield (0.968) is considerably higher than the industry average of (0.126). P/S Ratio (1.676) is also within normal values, averaging (1.476).

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. IPI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 82 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IPI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.

Notable companies

The most notable companies in this group are CF Industries Holding (NYSE:CF), Mosaic Company (The) (NYSE:MOS).

Industry description

The agricultural chemicals sector includes companies that produce chemical products for the agricultural industry applications like crop protection, animal health, biotechnology and pharmaceutical-related products. Some of the largest agricultural chemicals producers include Nutrien Ltd., Corteva Inc., and FMC Corporation.

Market Cap

The average market capitalization across the Chemicals: Agricultural Industry is 5.98B. The market cap for tickers in the group ranges from 611 to 33.5B. NTR holds the highest valuation in this group at 33.5B. The lowest valued company is BHILQ at 611.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Agricultural Industry was -0%. For the same Industry, the average monthly price growth was -13%, and the average quarterly price growth was -19%. FMC experienced the highest price growth at 41%, while NXTS experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Agricultural Industry was 13%. For the same stocks of the Industry, the average monthly volume growth was -51% and the average quarterly volume growth was -16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 37
P/E Growth Rating: 61
Price Growth Rating: 62
SMR Rating: 80
Profit Risk Rating: 78
Seasonality Score: -24 (-100 ... +100)
View a ticker or compare two or three
IPI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a producer of a potash and langbeinite

Industry ChemicalsAgricultural

Industry
Other Metals Or Minerals
Address
707 17th Street
Phone
+1 303 296-3006
Employees
478
Web
https://www.intrepidpotash.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of approximately $8.5 billion, a roughly 5% increase from $8.1 billion in Q1 2025. Consensus adjusted earnings per share (EPS) forecast stands at $4.74, reflecting a potential decline from prior-year levels amid pricing pressures.
Analysts expect Q1 2026 adjusted EPS of around $1.61, down from prior year levels due to softer commodity prices. Consensus revenue forecast stands at approximately $14.5 billion, reflecting a year-over-year decline.